Strategy | Finance Blog

Healthcare Private Placement and M&A Transactions Review Week Ending May 25, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions CellCentric: The company raised $120 million of Series C venture funding in a deal led by RA Capital Management and Forbion on May 19, 2025. Avego Management and BrightEdge also...

Technology Private Placement and M&A Transactions Review Week Ending May 18, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Perplexity: The company is in the process of raising $500 million of venture funding in a deal led by Accel on May 13, 2025, putting the company's pre-money valuation at $13.5...

Consumer Private Placement and M&A Transactions Review Week Ending May 18, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Owner: The company raised $120 million of venture funding in a deal led by Meritech Capital Partners and Headline on May 13, 2025, putting the company's pre-money valuation at $880...

Healthcare Private Placement and M&A Transactions Review Week Ending May 18, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Pathos: The company raised $365 million of Series D venture funding from undisclosed investors on May 15, 2025, putting the company's pre-money valuation at $1.24 billion. The...

Technology Private Placement and M&A Transactions Review Week Ending May 4, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Display.: The company raised $3.4 billion of venture funding from undisclosed investors on April 28, 2025. The company is a developer of a social platform designed to help creators...

Consumer Private Placement and M&A Transactions Review Week Ending May 4, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Gorgie: The company raised $24.5 million of Series A venture funding in a deal led by Notable Capital on April 29, 2025, putting the company's pre-money valuation at $80 million....

Healthcare Private Placement and M&A Transactions Review Week Ending May 4, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Pathos: The company raised $283 million of venture funding from undisclosed investors on May 1, 2025. The company is a developer of a drug discovery platform intended to reduce the...

Technology Private Placement and M&A Transactions Review Week Ending April 27, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Monarrch: The company raised $260 million of venture funding from undisclosed investors on April 25, 2025. The company, based in Nashville, Tennessee, and Melbourne, Australia,...

Consumer Private Placement and M&A Transactions Review Week Ending April 27, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Tosi: The company raised $25.9 million of Series B venture funding in a deal led by Cambridge Companies SPG on April 24, 2025. The company is a producer of protein bars, snacks, and...

Healthcare Private Placement and M&A Transactions Review Week Ending April 27, 2025
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions SHINE Technologies: The company received $122.5 million of development capital from undisclosed investors on April 21, 2025. The company is a developer of medical isotopes designed...